BASSI, SIMONA

BASSI, SIMONA  

Alma Mater Studiorum Universita' di Bologna  

Bassi S  

Risultati 1 - 7 di 7 (tempo di esecuzione: 0.007 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M. 2005-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.01 Articolo in rivista -
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients. Iacobucci I; Saglio G; Rosti G; Testoni N; Pane F; Amabile M; Poerio A; Soverini S; Bassi S; Cilloni D; Bassan R; Breccia M; Lauria F; Izzo B; Merante S; Frassoni F; Paolini S; Montefusco E; Baccarani M; Martinelli G 2006-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G; GIMEMA Working Party on Chronic Myeloid Leukemia 2008-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista -
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M.; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M. 2004-01-01 LEUKEMIA & LYMPHOMA - 1.01 Articolo in rivista -
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia BACCARANI M.; MARTINELLI G.; ROSTI G.; TRABACCHI E.; TESTONI N.; BASSI S.; AMABILE M.; SOVERINI S.; CASTAGNETTI F.; CILLONI D.; IZZO B.; DE VIVO A.; MESSA E.; BONIFAZI F.; POERIO A.; LUATTI S.; GIUGLIANO E.; ALBERTI D.; FINCATO G.; RUSSO D.; PANE F.; SAGLIO G.; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA 2004-01-01 BLOOD - 1.01 Articolo in rivista -
Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party. Rosti G; Iacobucci I; Bassi S; Castagnetti F; Amabile M; Cilloni D; Poerio A; Soverini S; Palandri F; Rege Cambrin G; Iuliano F; Alimena G; Latagliata R; Testoni N; Pane F; Saglio G; Baccarani M; Martinelli G. 2007-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista -
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia ROSTI G.; MARTINELLI G.; BASSI S.; AMABILE M.; TRABACCHI E.; GIANNINI B.; CILLONI D.; IZZO B.; DE VIVO A.; TESTONI N.; CAMBRIN G. R.; BONIFAZI F.; SOVERINI S.; LUATTI S.; GOTTARDI E.; ALBERTI D.; PANE F.; SALVATORE F.; SAGLIO G.; BACCARANI M.; STUDY COMMITTEE; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA ; WRITING COMMITTEE; 2004-01-01 BLOOD - 1.01 Articolo in rivista -